What HOMA-IR Is

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a calculated score derived from two simple fasting blood values: fasting glucose and fasting insulin. Together, they reveal how hard your pancreas is working to keep your blood sugar in a normal range. A low score means your cells respond efficiently to insulin with minimal amounts needed. A high score means they’ve become resistant — forcing the pancreas to produce progressively more insulin to achieve the same effect. This state of compensatory hyperinsulinemia is where the downstream damage begins.

A score below 1.0 is considered optimal. Scores above 1.9 suggest early resistance; above 2.9 indicates significant resistance. Standard medical workups often miss this entirely, because fasting glucose can remain normal for years while insulin is already elevated and quietly driving harm.

How Insulin Resistance Drives Chronic Disease

Insulin is far more than a blood sugar hormone — it’s one of the body’s most powerful signaling molecules, with receptors on virtually every tissue type. When cells become resistant to its signal, the downstream consequences extend well beyond glucose metabolism:

Type 2 diabetes — the direct and inevitable consequence of sustained, uncorrected resistance.

Cardiovascular disease — elevated insulin promotes arterial inflammation, endothelial dysfunction, dyslipidemia, and hypertension — all major drivers of heart attack and stroke.

Non-alcoholic fatty liver disease (NAFLD) — insulin resistance redirects excess glucose into hepatic fat storage, progressively impairing liver function.

Hormonal disruption — drives PCOS in women and suppresses testosterone production in men, accelerating hormonal decline.

Cognitive decline and Alzheimer’s disease — Alzheimer’s is strongly associated with impaired insulin signaling in the brain — sometimes referred to as “type 3 diabetes.”

Cancer — chronic hyperinsulinemia stimulates cellular proliferation pathways including mTOR and creates a pro-inflammatory, high-glucose environment that favors tumor growth.

Accelerated aging — insulin resistance drives systemic inflammation, oxidative stress, mitochondrial dysfunction, and glycation — four of the most well-characterized mechanisms of biological aging.

Why Addressing It Is Central to Longevity

Insulin sensitivity is among the most consequential biomarkers we have. Nearly every major age-related disease has insulin resistance somewhere in its causal chain. Restoring it doesn’t just reduce a single risk in isolation — it simultaneously improves cardiovascular health, hormonal balance, cognitive function, body composition, inflammatory status, and cellular repair capacity.

Meaningful improvement is achievable through targeted intervention:

At Rejuvecare

Measuring HOMA-IR as part of a comprehensive metabolic panel gives us a window into your health that standard screening often misses entirely. Identifying and correcting insulin resistance early — before it becomes visible on a glucose test — is one of the most impactful things you can do for your long-term health, and it sits at the core of our longevity medicine approach.